June 11, 2020 | Yahoo Finance Dr. Dadi Segal, CEO of Panaxia Global, said, “Receiving EU-GMP certification is a defining moment for us and for the
June 8, 2020 | Market Watch Dr. Dadi Segal, CEO of Panaxia Global, said, “Panaxia started 2020 with a strong quarter boasting expanded operations, record quarterly
April 10, 2020 | Reuters Specialty drugmaker Neuraxpharm has teamed up with Israel’s Panaxia Labs to market medical cannabis, saying it would be the first
April 9, 2020 | Cannabis Law Report Israel’s largest manufacturer and home-delivery distributor of medical cannabis products, Panaxia Labs Israel Ltd. (TASE: PNAX), announced a contractual agreement to use
April 6, 2020 | Yahoo Finance Dr. Dadi Segal, Panaxia CEO: “Using the Malta facility is a significant stepping stone as we enter the European market. We believe
April 3, 2020 |Benzinga Medical cannabis producer Panaxia Labs Israel Ltd. (TASE:PNAX) has finalized a 17 million ILS ($4.67 million) private placement of common stock and warrants to Israeli institutional
April 1, 2020 | Health Care Marketing Neuraxpharm has entered into an agreement with Panaxia Labs Israel to distribute and market medical cannabis products in
April 2, 2020 | Yahoo Finance Proceeds include a unilateral option for the investment of 6 million ILS by the company’s controlling shareholders and additional
April 01, 2020 | Benzinga European pharmaceutical company Neuraxpharm has teamed up with Israel medical cannabis producer Panaxia Labs Israel (TASE: PNAX) to begin marketing medical cannabis products. Neuraxpharm focuses on pharmaceutical products
April 1, 2020 | Investor Ideas Good afternoon and welcome to another episode of Investorideas.com “Potcast” featuring cannabis news, stocks to watch as well as